Credit and Fixed Income teams seem to be at the height of growth
More Product teams in the larger players are looking for change focused strategists
Both the Investment and Corporate worlds seem to be looking for a more quantitative approach to their strategy alignment; although the operational arm is certainly strengthening there is still a necessity for the front line strategists.
Growth seems to be global however the APAC market is concentrating on recruiting a talent pool that mirrors their client base.
Wealth and Retail Banking:
The Retail Banking, Wealth Management and Cards space is facing a period of change due to the impacts of high levels of new regulations, new digital technologies and increasing competition.
The Retail Banking market is at the forefront of everybody’s mind and are actively hiring at all levels to help drive these changes and grow this business area globally.
We would expect more opportunities over the next few months to become available within all areas particularly in the Cards and Payments space with the increasing new developments in this area worldwide.
Retailers are having to work harder than ever to demonstrate value-add to consumers through clever use range, availability, marketing, loyalty, etc
“Multi-channel” becomes extinct as retailers understand it’s all about “omni-channel”
Customisation is certainly becoming far less ‘nice to have’ to the ‘norm’
The FMCG market is growing significantly with more hires in Europe across varying levels.
Drinks, Manufacturers and Cosmetics are actively hiring around the Mid- to Senior Level and we expect more opportunities to be available across all levels over the next three months
Following the arrival of the “patent cliff”, the big pharma business model is finally starting to change:
Some large Pharma companies (Pfizer, AstraZeneca etc.) are reacting by cutting jobs, relocating their R&D facilities, and focusing more on the Emerging Markets.
Others (Sanofi, Roche etc.) decided to buy smaller biotechs with marketed drugs in order to protect themselves and boost revenue.
Generic manufacturers have been picking up these profits lost by big pharma (e.g. Watson v Pfizer) by quickly developing cheaper copies of the unprotected blockbusters.
Over the past few years, big pharma budgets have typically been focused more on the commercialisation of existing drugs rather than the development of new ones.
As big pharma looks to return to drug discovery, albeit with a relatively new approach, we will start to see the growth of these R&D / Innovation Strategy teams. The strategic link between R&D and the board is becoming increasingly important and candidates with both a heavy scientific background and strong commercial/strategy experience will be highly valued in 2014 onwards.
The demand for candidates in the TMT space is highest at the manager level
TMT businesses have the highest demand for candidates with a blend of industry and consulting experience
Within the TMT space we are most active in the telcos market, this is apparent across Europe and Western America. Naturally we envisage the Technology area to hire more in Quarter 3 with the media market hiring in peeks and troughs.
The Interim Strategy Market:
The Interim Strategy market is rapidly growing with clients exploring cost saving initiatives to bring on top tier freelance consultants for project work rather than working directly with a consultancy firm. Clients are keen to get individual consultants to come on board to be imbedded in teams offering their expertise and ideas. Temp to perm opportunities are also increasing offering a route to get people on board quicker and a ‘try before you buy’ approach.
Market in general is certainly picking up
Growth areas include Digital and Analytics
Rumours of a number of smaller firms being acquired by ’Big 4’